Monday, January 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

A New Buy Rating Sparks Interest in Quantum Computing Firm Rigetti

Andreas Sommer by Andreas Sommer
January 19, 2026
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software
0
Rigetti Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

The quantum computing sector is in focus this week following a significant analyst initiation. Rosenblatt Securities commenced coverage on Rigetti Computing with a bullish “Buy” recommendation, setting a price target of $40 per share. This projection suggests a potential upside of more than 56% from Friday’s closing price of $25.59.

Technical Hurdles and Revised Timelines

Despite the optimistic outlook from analysts, Rigetti confirmed a delay in its product roadmap. The general availability of its 108-qubit system, named Cepheus-1-108Q, has been pushed back. Initially planned for an earlier release, the system is now slated for market readiness by the end of the first quarter of 2026. The company attributed the shift to its pursuit of higher technical precision. While the current 2-qubit fidelity stands at 99%, Rigetti is targeting 99.5%. For context, the firm’s smaller 9-qubit systems already achieve a 99.7% fidelity rate. This metric is critical for computational reliability and is a key competitive factor against rivals like IonQ, which utilizes a different trapped-ion technology.

Sector-Wide Momentum and Financial Contrasts

The positive sentiment from analysts had already begun influencing the market last Friday. Rigetti’s shares advanced by 3.6%, while its competitors also saw gains. IonQ jumped 6.8%, and Quantum Computing Inc. rose 4.3%. This sector-wide movement occurred ahead of the Monday U.S. market holiday, with investors looking toward Tuesday’s trading session.

Should investors sell immediately? Or is it worth buying Rigetti?

Over a longer horizon, Rigetti’s stock performance has been remarkable, posting gains between 135% and 151% over the past twelve months. This significantly outpaces IonQ’s 83% increase over the same period. However, a stark contrast emerges in the companies’ financial fundamentals, highlighting Rigetti’s earlier developmental stage. Its revenue for the last twelve months totaled just $7 million, representing a 43% decline over three years. In comparison, IonQ reported $80 million in revenue, fueled by a growth rate of 493%.

Analyst Sentiment and Future Catalysts

Rosenblatt’s bullish stance aligns with other positive assessments in the market. Mizuho Securities recently reaffirmed its favorable view on the quantum computing specialist. The coming quarters will be pivotal for Rigetti. Market watchers will closely monitor progress on the Cepheus system and the company’s first-quarter financial results to determine if it can initiate a reversal in its revenue trend.

Ad

Rigetti Stock: Buy or Sell?! New Rigetti Analysis from January 19 delivers the answer:

The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 19.

Rigetti: Buy or sell? Read more here...

Tags: Rigetti
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

ImmunityBio Stock
Analysis

ImmunityBio Shares Surge on Clinical and Commercial Milestones

January 19, 2026
Arafura Stock
Analysis

Arafura Resources Nears Critical Funding Milestone for Flagship Project

January 19, 2026
Fannie Mae Stock
Analysis

Fannie Mae Shares Plunge on New Government Mortgage Mandate

January 19, 2026
Next Post
Arafura Stock

Arafura Resources Nears Critical Funding Milestone for Flagship Project

ImmunityBio Stock

ImmunityBio Shares Surge on Clinical and Commercial Milestones

Recommended

Nio Stock

Nio Shares Face Persistent Market Skepticism Despite Strong Delivery Growth

1 month ago
Lightbridge Stock

Lightbridge Shares Navigate Volatility Following Analyst Downgrade

4 months ago
Technology Blockchain Stock Market Today

Insider Sales at Meta Platforms Inc A Closer Look at Recent Transactions

2 years ago
Tenable Stock

Cybersecurity Leader Tenable Faces Growth Concerns Despite Market Dominance

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Fannie Mae Shares Plunge on New Government Mortgage Mandate

A Landmark Discovery for Max Power Mining

Legal Challenges Mount for DeFi Technologies Stock

Micron’s Strategic Acquisition to Accelerate Memory Production

Netflix Shares Face Critical Test Amid Acquisition Uncertainty

Rocket Lab Shares Surge on Analyst Upgrade Amid Insider Caution

Trending

ImmunityBio Stock
Analysis

ImmunityBio Shares Surge on Clinical and Commercial Milestones

by Dieter Jaworski
January 19, 2026
0

A convergence of robust clinical data, explosive revenue growth, and a key international regulatory approval has propelled...

Arafura Stock

Arafura Resources Nears Critical Funding Milestone for Flagship Project

January 19, 2026
Rigetti Stock

A New Buy Rating Sparks Interest in Quantum Computing Firm Rigetti

January 19, 2026
Fannie Mae Stock

Fannie Mae Shares Plunge on New Government Mortgage Mandate

January 19, 2026
Max Power Mining Stock

A Landmark Discovery for Max Power Mining

January 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio Shares Surge on Clinical and Commercial Milestones
  • Arafura Resources Nears Critical Funding Milestone for Flagship Project
  • A New Buy Rating Sparks Interest in Quantum Computing Firm Rigetti

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com